# ONMDW (Onemednet Corporation) - SEC EDGAR Financial Statements

> Onemednet Corporation reported $2.30M in revenue and a net loss of $10.43M for the trailing twelve months ended September 30, 2026 (up 478.0% year over year), with a -49.7% gross margin and a -440.0% operating margin.

- Canonical: https://convexityos.com/fundamentals/ONMDW
- Markdown: https://convexityos.com/fundamentals/ONMDW.md
- SEC CIK: 0001849380
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:01 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001849380&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $2.30M | +478.0% YoY |
| Operating Income | TTM | -$10.13M | -440.0% margin |
| Net Income | TTM | -$10.43M | -452.9% net margin |
| Diluted EPS | TTM | -$1.70 | Split-adjusted |
| Free Cash Flow | TTM | -$6.90M | -299.9% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $137K | Total debt: $563K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Revenue** | $1.36M | $643K | $1.02M | $1.15M |
| Cost of Revenue | $1.86M | $924K | $1.15M | $1.51M |
| **Gross Profit** | -$503K | -$281K | -$129K | -$361K |
| Research & Development | $1.51M | $1.47M | $2.06M | $953K |
| Selling, General & Admin | $7.65M | $7.86M | $4.66M | $9.71M |
| Total Operating Expenses | $9.16M | $9.32M | $6.72M | $11.06M |
| **Operating Income** | -$9.67M | -$9.61M | -$6.85M | -$11.43M |
| **EBITDA** | -$9.60M | -$9.55M | -$6.83M | -$11.40M |
| Interest Expense | $67K | $147K | $749K | $403K |
| Income Before Tax | -$2.80M | -$10.13M | -$33.76M | $552K |
| Income Tax Expense | $1.0K | $2.0K | $18K | $215K |
| **Net Income** | -$2.80M | -$10.13M | -$33.78M | -$6.23M |
| Basic EPS | -$0.06 | -$0.36 | -$4.65 | -- |
| **Diluted EPS** | -$0.06 | -$0.36 | -$4.65 | $0.03 |
| Basic Shares Outstanding | 44.5M | 28.1M | 7.3M | -- |
| Diluted Shares Outstanding | 44.5M | 28.1M | 7.3M | -- |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.02M | $292K | $96K | $891K | $177K | $155K | $137K | $26K |
| Cost of Revenue | $1.39M | $857K | $476K | $726K | $399K | $396K | $361K | $52K |
| **Gross Profit** | -$363K | -$565K | -$380K | $165K | -$222K | -$241K | -$224K | -$26K |
| Research & Development | $424K | $324K | $311K | $443K | $323K | $382K | $348K | $340K |
| Selling, General & Admin | $1.45M | $1.37M | $1.86M | $2.80M | $1.69M | $1.44M | $1.65M | $2.35M |
| Total Operating Expenses | $1.87M | $1.70M | $2.17M | $3.25M | $2.01M | $1.82M | $2.00M | $2.69M |
| **Operating Income** | -$2.23M | -$2.26M | -$2.55M | -$3.08M | -$2.23M | -$2.06M | -$2.22M | -$2.72M |
| **EBITDA** | -- | -- | -$2.54M | -$3.07M | -$2.23M | -$2.03M | -$2.21M | -$2.69M |
| Interest Expense | $8.0K | $9.0K | $10K | $8.0K | $6.0K | $22K | $31K | $27K |
| **Net Income** | -$2.66M | -$2.17M | -$2.45M | -$3.14M | -$741K | $2.98M | -$1.90M | -$2.37M |
| Basic EPS | -$0.43 | -$0.04 | -$0.04 | -- | -$0.14 | $0.07 | -$0.06 | -- |
| **Diluted EPS** | -$0.43 | -$0.04 | -$0.04 | -- | -$0.14 | $0.07 | -$0.06 | -- |
| Basic Shares Outstanding | 6.1M | 58.0M | 55.3M | -- | 5.3M | 36.8M | 34.1M | -- |
| Diluted Shares Outstanding | 6.1M | 58.0M | 55.3M | -- | 5.3M | 38.4M | 34.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $585K | $172K | $47K | $302K | $453K |
| **Cash & Short-Term Investments** | $585K | $172K | $47K | $302K | $453K |
| Accounts Receivable, Net | $495K | $213K | $152K | $19K | -- |
| **Total Current Assets** | $2.10M | $3.62M | $365K | $30.35M | $536K |
| Property, Plant & Equipment, Net | $56K | $108K | $99K | $83K | -- |
| **Total Non-Current Assets** | $56K | $108K | $99K | $83K | $117.3M |
| **Total Assets** | $2.15M | $3.73M | $464K | $30.43M | $117.9M |
| Accounts Payable | $3.20M | -- | -- | -- | -- |
| Short-Term Debt | $974K | $9.38M | $465K | -- | -- |
| Deferred Revenue (Current) | $389K | $561K | $254K | $184K | -- |
| Other Current Liabilities | -- | $283K | $283K | $12K | -- |
| **Total Current Liabilities** | $4.83M | $19.23M | $13.84M | $11.78M | $290K |
| Other Non-Current Liabilities | -- | $449K | $68K | $207K | -- |
| **Total Non-Current Liabilities** | $291K | $449K | $68K | $9.38M | $8.88M |
| **Total Liabilities** | $5.12M | $19.68M | $13.91M | $21.16M | $9.17M |
| **Total Debt (incl. Leases)** | $974K | $9.38M | $465K | -- | -- |
| Common Stock | $1.0K | $2.0K | $2.0K | $455 | -- |
| Retained Earnings | -$104.4M | -$101.6M | -$91.44M | -$43.51M | -$8.61M |
| **Total Stockholders' Equity** | -$2.96M | -$15.95M | -$13.44M | -$26.36M | $14.44M |
| Total Equity | -$2.96M | -$15.95M | -$13.44M | -$26.36M | $14.44M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $137K | $358K | $233K | $585K | $149K | $122K | $144K | $172K |
| **Cash & Short-Term Investments** | $137K | $358K | $233K | $585K | $149K | $122K | $144K | $172K |
| Accounts Receivable, Net | $2.27M | $664K | $697K | $495K | $582K | $254K | $247K | $213K |
| **Total Current Assets** | $2.56M | $1.31M | $1.46M | $2.10M | $1.45M | $2.27M | $1.63M | $3.62M |
| Property, Plant & Equipment, Net | $44K | $51K | $47K | $56K | $60K | $70K | $101K | $108K |
| **Total Non-Current Assets** | $44K | $51K | $47K | $56K | $60K | $70K | $101K | $108K |
| **Total Assets** | $2.61M | $1.36M | $1.51M | $2.15M | $1.51M | $2.34M | $1.73M | $3.73M |
| Accounts Payable | -- | -- | -- | $3.20M | $3.20M | $1.30M | -- | -- |
| Short-Term Debt | $563K | $701K | $837K | $974K | -- | -- | $2.33M | $9.38M |
| Deferred Revenue (Current) | $1.48M | $683K | $679K | $389K | $770K | $512K | $503K | $561K |
| Other Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $283K |
| **Total Current Liabilities** | $6.70M | $4.73M | $5.36M | $4.83M | $5.00M | $6.16M | $18.15M | $19.23M |
| Other Non-Current Liabilities | -- | -- | -- | -- | $440K | $18K | $128K | $449K |
| **Total Non-Current Liabilities** | $540K | $156K | $231K | $291K | $440K | $18K | $128K | $449K |
| **Total Liabilities** | $7.24M | $4.88M | $5.59M | $5.12M | $5.45M | $6.18M | $18.28M | $19.68M |
| **Total Debt (incl. Leases)** | $563K | $701K | $837K | $974K | -- | -- | $2.33M | $9.38M |
| Common Stock | $1.0K | $5.0K | $5.0K | $1.0K | $2.0K | $2.0K | $2.0K | $2.0K |
| Retained Earnings | -$111.7M | -$109.0M | -$106.8M | -$104.4M | -$101.2M | -$100.5M | -$103.5M | -$101.6M |
| **Total Stockholders' Equity** | -$4.63M | -$3.52M | -$4.08M | -$2.96M | -$3.94M | -$3.84M | -$16.55M | -$15.95M |
| Total Equity | -$4.63M | -$3.52M | -$4.08M | -$2.96M | -$3.94M | -$3.84M | -$16.55M | -$15.95M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Net Income | -$2.80M | -$10.13M | -$33.78M | $337K |
| Depreciation & Amortization | $65K | $57K | $28K | $25K |
| Stock-Based Compensation | $2.03M | $628K | $1.48M | $1.60M |
| Change in Receivables | -$282K | -$61K | -$133K | $73K |
| **Operating Cash Flow** | -$7.50M | -$6.95M | -$4.79M | $87.24M |
| Capital Expenditure | -$13K | -$51K | -$44K | -$58K |
| **Free Cash Flow** | -$7.52M | -$7.00M | -$4.83M | $87.18M |
| **Investing Cash Flow** | $2.31M | -$1.98M | -$44K | -$2.25M |
| **Financing Cash Flow** | $5.61M | $9.06M | $4.61M | -$88.03M |
| **Net Change in Cash** | $413K | $125K | -$224K | -$851K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.66M | -$2.17M | -$2.45M | -$3.14M | -$741K | $2.98M | -$1.90M | -$2.37M |
| Depreciation & Amortization | -- | -- | $11K | $9.0K | $10K | $34K | $12K | $26K |
| Stock-Based Compensation | $458K | $463K | $431K | $1.49M | $142K | $197K | $208K | $181K |
| Change in Receivables | -$1.61M | $33K | -$202K | $87K | -$328K | -$7.0K | -$34K | -$150K |
| **Operating Cash Flow** | -$1.42M | -$1.88M | -$1.54M | -$2.05M | -$1.41M | -$2.19M | -$1.85M | -$2.00M |
| Capital Expenditure | -$1.0K | -$9.0K | -$2.0K | -$5.0K | $0 | -$3.0K | -$5.0K | -$35K |
| **Free Cash Flow** | -$1.42M | -$1.88M | -$1.54M | -$2.05M | -$1.41M | -$2.19M | -$1.86M | -$2.03M |
| **Investing Cash Flow** | -$1.0K | $56K | $352K | -$51K | $1.11M | -$670K | $1.92M | $365K |
| **Financing Cash Flow** | $1.20M | $1.94M | $838K | $2.54M | $331K | $2.84M | -$94K | -$131K |
| **Net Change in Cash** | -$221K | $125K | -$352K | $436K | $27K | -$22K | -$28K | -$1.76M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Gross Margin** | -37.0% | -43.7% | -12.6% | -31.3% |
| **Operating Margin** | -711.3% | -1493.8% | -671.2% | -991.2% |
| **Net Profit Margin** | -206.1% | -1575.3% | -3308.5% | -540.4% |
| Return on Assets (ROA) | -130.2% | -271.8% | -7280.2% | -20.5% |
| Current Ratio | 0.43x | 0.19x | 0.03x | 2.58x |
| Quick Ratio | 0.22x | 0.02x | 0.01x | 0.03x |
| **Revenue Growth (YoY)** | +111.4% | -37.0% | -11.4% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -105.5% | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -105.5% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -49.7% | -68.8% | -51.4% | -38.4% | -144.0% | -125.0% | -82.0% | -43.7% |
| **Operating Margin** | -440.0% | -695.7% | -753.0% | -706.2% | -1866.3% | -2030.2% | -1828.9% | -1494.1% |
| **Net Profit Margin** | -452.9% | -584.2% | -254.1% | -206.0% | -410.9% | -728.5% | -1865.0% | -1575.3% |
| Return on Assets (ROA) | -399.6% | -623.6% | -222.4% | -130.2% | -135.1% | -143.4% | -572.9% | -271.8% |
| Current Ratio | 0.38x | 0.28x | 0.27x | 0.43x | 0.29x | 0.37x | 0.09x | 0.19x |
| Quick Ratio | 0.36x | 0.22x | 0.17x | 0.22x | 0.15x | 0.06x | 0.02x | 0.02x |
| **Revenue Growth (YoY)** | +478.0% | +88.4% | -29.9% | +3326.9% | +24.6% | -31.7% | -44.8% | -92.4% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -1400.0% |
| **Net Income Growth (YoY)** | -- | -172.8% | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -157.1% | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
